PAPER Chen Z, Li G, Liu J
SEARCH RESULTS
1471 RESULTS
PAPER Afitska K, Priss A, Yushchenko DA, Shvadchak VV
Structural Optimization of Inhibitors of α-Synuclein Fibril Growth: Affinity to the Fibril End as a Crucial Factor.
J Mol Biol. 2020 Feb 14;432(4):967-977. Epub 2019 Dec 3 PubMed: 31809698PAPER Moon SP, Balana AT, Galesic A, Rakshit A, Pratt MR
Ubiquitination Can Change the Structure of the α-Synuclein Amyloid Fiber in a Site Selective Fashion.
J Org Chem. 2020 Feb 7;85(3):1548-1555. Epub 2019 Dec 19 PubMed: 31809571PAPER Pietrek LM, Stelzl LS, Hummer G
Hierarchical Ensembles of Intrinsically Disordered Proteins at Atomic Resolution in Molecular Dynamics Simulations.
J Chem Theory Comput. 2020 Jan 14;16(1):725-737. Epub 2019 Dec 26 PubMed: 31809054PAPER Goldstein DS
The catecholaldehyde hypothesis: where MAO fits in.
J Neural Transm (Vienna). 2020 Feb;127(2):169-177. Epub 2019 Dec 5 PubMed: 31807952PAPER Tu D, Gao Y, Yang R, Guan T, Hong JS, Gao HM
The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration.
J Neuroinflammation. 2019 Dec 5;16(1):255. PubMed: 31805953PAPER Tremolizzo L, Lizio A, Santangelo G, Diamanti S, Lunetta C, Gerardi F, Messina S, La Foresta S, Riva N, Falzone Y, Filippi M, Woolley SC, Sansone VA, Siciliano M, Ferrarese C, Appollonio I, ALS-CBS Italian Study Group
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability.
Neurol Sci. 2020 Apr;41(4):835-841. Epub 2019 Dec 5 PubMed: 31807998PAPER Ludwig N, Fehlmann T, Kern F, Gogol M, Maetzler W, Deutscher S, Gurlit S, Schulte C, von Thaler AK, Deuschle C, Metzger F, Berg D, Suenkel U, Keller V, Backes C, Lenhof HP, Meese E, Keller A
Machine Learning to Detect Alzheimer's Disease from Circulating Non-coding RNAs.
Genomics Proteomics Bioinformatics. 2019 Aug;17(4):430-440. Epub 2019 Dec 4 PubMed: 31809862PAPER Gong Y, Chen J, Jin Y, Wang C, Zheng M, He L
GW9508 ameliorates cognitive impairment via the cAMP-CREB and JNK pathways in APPswe/PS1dE9 mouse model of Alzheimer's disease.
Neuropharmacology. 2020 Mar 1;164:107899. Epub 2019 Dec 3 PubMed: 31809762PAPER Singh AK, Mishra SK, Mishra G, Maurya A, Awasthi R, Yadav MK, Atri N, Pandey PK, Singh SK
Inorganic clay nanocomposite system for improved cholinesterase inhibition and brain pharmacokinetics of donepezil.
Drug Dev Ind Pharm. 2020 Jan;46(1):8-19. Epub 2019 Dec 6 PubMed: 31809608PAPER Van Stavern GP
Current opinion neurology: visual pathway biomarkers in Alzheimer's disease.
Curr Opin Neurol. 2020 Feb;33(1):79-86. PubMed: 31809334PAPER Yin J, Nielsen M, Carcione T, Li S, Shi J
Apolipoprotein E regulates mitochondrial function through the PGC-1α-sirtuin 3 pathway.
Aging (Albany NY). 2019 Dec 6;11(23):11148-11156. PubMed: 31808750PAPER Arslan T, Buğrahan Ceylan M, Baş H, Biyiklioglu Z, Senturk M
Design, synthesis, characterization of peripherally tetra-pyridine-triazole-substituted phthalocyanines and their inhibitory effects on cholinesterases (AChE/BChE) and carbonic anhydrases (hCA I, II and IX).
Dalton Trans. 2020 Jan 7;49(1):203-209. Epub 2019 Dec 6 PubMed: 31808483PAPER Madhu P, Mukhopadhyay S
Preferential Recruitment of Conformationally Distinct Amyloid-β Oligomers by the Intrinsically Disordered Region of the Human Prion Protein.
ACS Chem Neurosci. 2020 Jan 2;11(1):86-98. Epub 2019 Dec 20 PubMed: 31808343PAPER Jia W, Rajani C, Kaddurah-Daouk R, Li H
Expert insights: The potential role of the gut microbiome-bile acid-brain axis in the development and progression of Alzheimer's disease and hepatic encephalopathy.
Med Res Rev. 2019 Dec 5; PubMed: 31808182Current Filters
- Date Range : Nov 2019 to Dec 2019 x